Memory formation depends on intricate molecular machinery that maintains neural connections, and disruption of these systems may accelerate cognitive decline. Understanding how specific enzymes preserve brain structure could reveal new therapeutic targets for neurodegenerative conditions affecting millions of aging adults. The enzyme GalNAc-T13 emerges as a critical regulator of memory retention through its role in O-GalNAc glycosylation, a process that adds sugar modifications to proteins. This enzyme specifically targets seizure protein 6 (Sez6), a membrane protein essential for maintaining neurite architecture—the branching extensions that allow neurons to communicate. When GalNAc-T13 function is compromised, the glycosylation of Sez6 becomes deficient, leading to deterioration of neural connections and subsequent memory impairments. The research demonstrates that this glycosylation pathway directly influences synaptic stability and cognitive function. This finding illuminates a previously underappreciated mechanism linking protein glycosylation to memory preservation. O-GalNAc glycosylation represents the brain's predominant form of protein modification, yet its specific roles in cognitive function have remained largely mysterious. The identification of the GalNAc-T13-Sez6 axis provides concrete evidence that disrupted glycosylation patterns may contribute to age-related memory decline. However, this appears to be foundational research, likely conducted in model organisms, which limits immediate clinical applications. The specificity of this enzyme-substrate relationship suggests potential for targeted interventions, though translating glycosylation-based therapies to humans presents significant challenges. This work represents incremental but important progress in understanding how post-translational modifications preserve cognitive function, potentially opening new avenues for neuroprotective strategies focused on maintaining proper protein glycosylation patterns throughout aging.